SURFACTANT-ASSOCIATED PROTEINS (SP) are important to the expression of surface activity of pulmonary surfactants (17) , lipid metabolism (7) , and pulmonary defense (20) . In particular, hydrophobic proteins, such as SP-B and SP-C, are considered vital to the surface activity of surfactants (6, 31) . These proteins are secreted with lipids from alveolar type II cells and promote surface adsorption of lipid molecules at the air-water interface. Although some of these proteins are recycled by alveolar type II cells (3, 16) , some are ingested and metabolized by alveolar macrophages (4, 30) . The metabolic fate of such proteins is not fully understood.
In pulmonary alveolar proteinosis (PAP), a large amount of dimeric form of SP-C ([SP-C] 2 ) accumulates in the lung (18, 26) . Fused-membrane structures, unique structures found in insoluble material of bronchoalveolar lavage fluid (BALF) and in macrophages in PAP lungs (9) , are composed of dimeric and monomeric forms of SP-C (19) . We hypothesized that [SP-C] 2 accumulated in the patients' lungs because of its undigestability by macrophages.
To demonstrate differences in the mode of removal between SP-C and [SP-C] 2 , we examined the fate of these proteins in the mouse lung after intratracheal instillation of liposomes containing the proteins obtained from PAP patients. In this experiment, we focused on the interconversion of [SP-C] 2 to its monomeric form and the participation of glutathione (GSH), a major reducing substance, in the conversion.
MATERIALS AND METHODS
Lipids and reagents. L-␣-Dipalmitoylphosphatidylcholine (DPPC) and L-␣-phosphatidylglycerol from egg were purchased from Sigma Chemical (St. Louis, MO). Succinimidyl-6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-amino hexanoic acid (NBD) was purchased from Molecular Probes (Eugene, OR). Reduced and oxidized glutathione (GSH and GSSG); GSH reductase; 5,5Ј-dinitro-bis(2-nitrobenzoic acid); NADPH; and lactate dehydrogenase (LDH) assay kit (LDH CII-test Wako) were purchased from Wako Pure Chemical Industries (Osaka, Japan). L-Buthionine-(S,R)-sulfoximine (BSO), diamide (DA), N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES), and organic solvents were obtained from Nacalai Tesque (Kyoto, Japan). 2 . SP-C and [SP-C] 2 were isolated from BALF obtained from patients with PAP who received therapeutic lung lavage in the Chest Disease Research Institute Hospital, Kyoto University. BALF was centrifuged at 16,000 g for 30 min at 4°C. The precipitate was extracted with chloroform-methanol according to the method of Folch and colleagues (8) . After organic solvents were evaporated, the residue was dissolved in chloroform-methanol-0.1 M HCl (1:1:0.1) and applied to a Sephadex LH60 column (Pharmacia Biotechnology, Uppsala, Sweden) (6) .
Isolation of SP-C and [SP-C]
Hydrophobic proteins eluted by the same solvent were examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (12.5%) according to the method of Weber and Osborn (28) and were separately pooled. Protein concentration was determined by the method of Thompson and Morrison (21) , and the purity of proteins was examined by SDS-PAGE and by amino acid composition analysis (19) . Proteins were stored in the elution solvent at Ϫ20°C until used.
Preparation of fluorescence-labeled proteins. Proteins were dried with a rotary evaporator, redissolved in chloroformmethanol (2:1), and reacted with NBD after adjusting the pH to 7 with HEPES buffer (pH 8.5) according to the method of Horowitz and colleagues (12) . Unreacted reagent was removed by Sephadex LH60 column chromatography, and labeled SP-C and [SP-C] 2 (referred to as NBD-SP-C and NBD-[SP-C] 2 , respectively) were stored at Ϫ20°C. The surface activity of lipid-protein complexes examined by a pulsating bubble surfactometer (Electronetics, Amherst, NY) did not differ between labeled and unlabeled proteins.
Preparation of liposomes. Mixtures of DPPC and egg L-␣-phosphatidylglycerol (4:1) in chloroform were combined with NBD-SP-C (1 and 2% by weight) or NBD-[SP-C] 2 (2% by weight), and solvents were dried under nitrogen and in vacuo. Liposomes were prepared by sonication after addition of phosphate-buffered saline (pH 7.4) [10 mg phospholipids (PL)/ml] and were then centrifuged at 100,000 g for 40 min at 4°C. Precipitate was suspended in sterile physiological saline (10 mg PL/ml) and stored at Ϫ20°C. In some experiments, liposomes containing NBD-[SP-C] 2 were incubated with 10 mM GSH at 37°C for 2 h and centrifuged at 100,000 g for 40 min at 4°C (referred to as GSH-treated NBD-[SP-C] 2 ). The precipitate was suspended again in saline at a concentration of 10 mg PL/ml.
Determination of PL, GSH, and LDH in the lung wash. Specific-pathogen-free female BALB/c mice were purchased from Shimizu Animal Laboratory (Kyoto, Japan) and were used at the age of 9-11 wk in the following experiments. To establish the optimal sampling conditions for determination of GSH level in alveoli, intra-alveolar PL, GSH, and LDH content was determined by sequential lung lavage in normal mice. Mice were killed by exsanguination from the aorta under pentobarbital sodium anesthesia (60 mg/kg), and lungs were perfused from the pulmonary artery with saline containing heparin (10 U/ml). The trachea was cannulated with a 19-gauge needle. Lungs were lavaged with 1 ml of saline, flushed in and out of the lungs three times, and the final wash was recovered. This procedure was repeated six times, and each lavage fluid was centrifuged at 150 g for 10 min at 4°C to remove cells. The supernatant was further centrifuged at 20,000 g for 40 min at 4°C. The white precipitate (white layer) was used for the determination of total PL according to the method of Bartlett (2) after extraction with chloroformmethanol. The total GSH in the supernatant was determined according to the method of Tietze (22) , and LDH was determined with a commercial kit.
Disappearance of intratracheally instilled labeled proteins. Mice were anesthetized with pentobarbital sodium (60 mg/ kg), and the trachea of each was exposed by making an incision in the neck. Animals were placed in the dorsal position on a surgical board set at an oblique angle of ϳ80°. The liposome suspension (total volume of 0.1 ml for 1 animal), containing either NBD-SP-C, NBD-[SP-C] 2 , or GSH-treated NBD-[SP-C] 2 , was instilled into the trachea through a 27-gauge needle by dividing the suspension into five aliquots. After instillation was performed, control mice were killed at time 0 by cutting the abdominal aorta. After their incisions were sutured, other mice were kept in an animal room (24 Ϯ 1°C, humidity 45 Ϯ 5%) with free intake of food and water. They were killed at various time intervals after instillation. Lungs were lavaged seven times with 1 ml of saline as described above. Combined lavage fluid and excised lungs, homogenized with 1 ml of saline, were extracted with chloroform-methanol. Solvents were evaporated, and the residue was dissolved in 5 ml of chloroform. A portion of the extract was used to determine total recovery of fluorescence-labeled proteins with a fluorescence spectrophotometer (F-2000; Hitachi, Tokyo, Japan). The recovery was expressed as a percentage of the total amount of fluorescence instilled into the lung. Efficiency of extraction of NBD-SP-C added to lavage fluid and to tissues was 93 and 80%, respectively. The rest of the lipid and protein extract was separated on a Sephadex LH60 column to examine the interconversion of NBD-[SP-C] 2 to NBD-SP-C and vice versa. Percentage of conversion was calculated from areas corresponding to original NBDproteins and converted proteins on chromatograms (see Fig. 3) which were measured by an image analyzer (JIM-5000; JEOL, Tokyo, Japan). Characterization of converted proteins was done by SDS-PAGE under reducing and nonreducing conditions.
Inhibition of in vivo conversion of NBD-[SP-C] 2 to NBD-SP-C by BSO and DA.
To determine the effect of GSH in the conversion of [SP-C] 2 to SP-C, BSO (18 mg, corresponding to ϳ3 mmol/kg) was injected subcutaneously and DA was injected intraperitoneally at 4 and 2 h, respectively, before intratracheal instillation of liposomes containing NBD-[SP-C] 2 (see Fig. 5 ). Animals killed 4 h after instillation received an additional DA injection 2 h before being killed. Those killed at 8 h after instillation received additional BSO (9 mg) 3 h before being killed and two additional DA injections at 3 and 6 h before they were killed. We examined two different doses of DA (0.3 and 2 mg, corresponding to 0.07 and 0.5 mmol/kg). Animals were killed as described above, and lungs were homogenized with 1 ml of saline containing 0.5 mM DA to inhibit conversion by free GSH during homogenization. The total recovery and the amount of SP-C formed were determined as described above.
Total GSH concentration in lavage fluids as well as GSH and GSSG content were determined in the lung homogenate of the animals (without instillation of liposomes) treated with a higher dose of DA. GSH concentration was determined as described above, except that only the first lung wash was obtained. After lavage was performed, lungs were homogenized with 2 ml of 5% trichloroacetic acid in 0.01 M HCl and centrifuged at 17,000 g for 15 min at 2°C. The supernatant was used for the determination of GSH and GSSG concentrations.
In Inhibition by DA in this system was also performed. After liposomes were incubated, proteins were extracted with chloroform-methanol and then analyzed as described above. To examine the effect of GSH on unlabeled proteins, we prepared liposomes from total lipid extracts of BALF from patients (6 mg PL, 0.35 mg SP-B, 0.23 mg [SP-C] 2 , and 0.24 mg SP-C). Liposomes were incubated with 10 mM GSH at 37°C for 2 h in 3 ml of reaction buffer, and proteins were examined with SDS-PAGE after separation from lipids by Sephadex LH60 column chromatography. The relative abundance of [SP-C] 2 and SP-C was determined after SDS-PAGE by staining with Coomassie brilliant blue and by densitometry (Densitron; JOOKOO, Kawasaki, Japan).
Statistical analysis. Commercially available computer software was used to analyze differences of the means between groups by nonpaired Student's t-test (StatView; Abacus Concepts, Berkeley, CA) and to obtain disappearance curves and half-lives of fluorescence-labeled proteins (CA-Cricket Graph III; Computer Associates International, Hauppauge, NY).
RESULTS
Content of PL, GSH, and LDH in mouse lung was evaluated in sequential lung washings. As shown in Fig. 1 , total amount of PL in seven washings decreased exponentially, and the first wash contained about onehalf of the total PL recovered by seven washings. GSH content, however, increased after the second wash and decreased gradually after the fourth wash. We decided to use the first wash to determine intra-alveolar GSH content in the following experiments. Figure 2 shows the recovery of proteins after intratracheal instillation of liposomes containing 1 and 2% NBD-SP-C and 2% NBD-[SP-C] 2 relative to the total amount of instilled proteins. These three regression curves were statistically significant (r 2 than NBD-SP-C was removed. By using regression analysis, we found that the difference in the regression slopes between NBD-[SP-C] 2 and 1% SP-C was statistically significant (P Ͻ 0.001) but that the difference in the two regression intercepts was not significant.
As shown in Fig. 3 , both proteins showed elution profiles different from the original proteins in liposomes. In NBD-SP-C, a small shoulder appeared before the main original SP-C peak, which was eluted at the fractions corresponding to those of NBD-[SP-C] 2 . In NBD-[SP-C] 2 , a relatively large second peak was found at the elution position corresponding to SP-C. The SDS-PAGE profile of the protein fractions obtained by the column is shown in Fig. 4 . In NBD-[SP-C] 2 , two bands were found, one corresponding to original protein and the other migrating at the position of NBD-SP-C (lane 3). In SP-C, when total proteins recovered were examined, no obvious band corresponding to a dimeric form was found (lane 4). But when only the fractions corresponding to [SP-C] 2 were examined, a very faint band migrating at the position of a dimer was found (lane 5), and this band disappeared after reduction with 2-mercaptoethanol (lane 6). These results show that a significant amount of NBD-[SP-C] 2 was converted to the monomeric form; however, the conversion of SP-C to the dimeric form, although it did occur, was not remarkable.
We then examined whether the conversion of NBD-[SP-C] 2 to NBD-SP-C was mediated through GSH. GSH content in the lung after BSO and DA treatment is shown in Fig. 5 . Intra-alveolar GSH concentration decreased to about one-fourth of control levels after 4 h of BSO treatment and 2 h of DA treatment at the time when liposomes were instilled. However, content of GSH in the lung tissue decreased gradually after 2 h of instillation and attained one-half of the control value at 4 and 8 h after instillation. GSSG content increased from 2 h after instillation and attained 20% of total GSH at 8 h after instillation. The conversion of NBD-[SP-C] 2 to NBD-SP-C in control and BSO-and DAtreated groups over a short period is shown in Fig. 6 . In the control group, SP-C increased steadily from 2 h after instillation of liposomes. The mean conversion rate from 2 to 8 h was calculated to be 0.22 µg·h Ϫ1 · mouse Ϫ1 (y ϭ 0.217x-0.166). In BSO-and DAtreated groups, the amount of SP-C formed was significantly lower at 4 h after instillation in the group treated with a low dose of DA (P Ͻ 0.05) and was significantly lower at all time points examined in the group treated with a high dose of DA (P Ͻ 0.05). Figure 7 shows the distribution of fluorescence between lavage fluid and lung tissue in controls and in the group given GSH-treated liposomes at 0 and 24 h after instillation. At time 0, in liposomes containing NBD-[SP-C] 2 pretreated with GSH, 23.1 Ϯ 1.9% were found as NBD-SP-C and this increased to 30.4 Ϯ 1.9% at 24 h. These values were significantly higher than those of control NBD-[SP-C] 2 (P Ͻ 0.001, see Table 1 ). The GSH-treated NBD-[SP-C] 2 was removed from lavage fluid faster than untreated NBD-[SP-C] 2 (P Ͻ 0.05) at 24 h after instillation. In comparison with NBD-SP-C, a larger fraction of NBD-[SP-C] 2 was recovered in lung tissue than in lung lavage. Although a higher percentage of NBD-SP-C was recovered in lavage fluid in liposomes containing 1% SP-C than in those with 2% SP-C (96.0 Ϯ 0.7 vs. 89.0 Ϯ 3.3%) at time 0, no differences were seen in the distribution between lavage fluid and tissue at 24 h after instillation (data not shown).
In vitro conversion of SP-C from a dimeric to a monomeric form by GSH was examined. Because total protein concentration did not change during incubation, the results were expressed as percentages of SP-C formed. The reaction was temperature-, time-, and concentration-dependent as shown in Fig. 8, A with GSH in reconstituted liposomes, a further 15% were converted to SP-C monomer (data not shown). Direct addition of GSH-containing buffer to dried lipids and proteins did not increase the conversion efficiency. These results suggested that the disulfide linkage of more than one-half of the proteins occurs in a hydrophobic environment that inhibits contact between GSH and proteins. Decrease in GSH concentration from 1 to 0.1 mM decreased the conversion only to about one-half (Fig. 8B) . DA inhibited the conversion more effectively in vitro than in vivo, and inhibition was almost complete at a DA concentration of one-half of the GSH concentration (0.2 mM DA vs. 0.4 mM GSH) (Fig. 8C) . Figure 9 shows the SDS-PAGE profile of unlabeled proteins treated with GSH in vitro. The bands corresponding to [SP-C] 2 became faint compared with those of SP-C. Similar changes were observed in SP-B, and new bands appeared that migrated faster than SP-B. Relative abundance of [SP-C] 2 to SP-C on SDS-PAGE was determined by densitometry in liposomes treated with GSH (Fig. 10) . GSH treatment significantly lowered the ratio from 0.81 to 0.58 (P Ͻ 0.05).
DISCUSSION
The PL content in the first of the sequential lung washes was about one-half of the total intra-alveolar Values are means Ϯ SE, in %. NBD, succinimidyl-6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-amino hexanoic acid; NBD-SP-C, surfactantassociated protein C fluorescently labeled with NBD; NBD-[SP-C] 2 , dimeric form of NBD-SP-C. NBD-[SP-C] 2 was instilled as liposomes of dipalmitoylphosphatidylcholine and phosphatidylglycerol from egg (4:1) at a lipid-to-protein ratio of 50:1. Lungs were lavaged 7 times with 1 ml of saline, and tissues were homogenized with 1 ml saline. %Total was calculated from recovery of proteins and %con-verted proteins in lavage and in tissue. Calculated total is based on results: conversion rate of NBD-[SP-C] 2 to NBD-SP-C (0.22 µg·h Ϫ1 · mouse Ϫ1 ); half-lives of 2% NBD-[SP-C] 2 and 1% NBD-SP-C, 37.5 and 17.7 h, respectively. PL. The rapid increase in GSH after the second wash was possibly caused by leakage from cells without cell disintegration, because the increase in GSH preceded the increase in LDH. These results suggest that the content of GSH in the first wash (0.6 µg/lungs) represents one-half of the actual intra-alveolar content of GSH (1.2 µg). Intra-alveolar concentration of GSH is, therefore, calculated to be 0.4-0.8 mM, assuming that the original alveolar lining fluid is 5-10 µl (total area, 1,000 cm 2 ; mean depth of lining layer, 0.05-0.1 µm) (29) .
[SP-C] 2 has been detected in lungs in several studies (1, 5, 18, 26, 27) . Interconversion between the monomer and dimer has been suspected (5) and was demonstrated in the present experiment. Furthermore, we have shown that GSH participates in this conversion.
Supposing the conversion of NBD-SP-C to NBD-[SP-C] 2 to be negligible, the half-life of NBD-SP-C was shown to be almost the same in liposomes containing different contents of SP-C: 17.7 h for liposomes containing 1% SP-C and 18.8 h for those with 2% SP-C. This suggests that the clearance pathways of SP-C are not saturable under the present experimental conditions. Pettenazzo and colleagues (15) reported that the clearance pathways of DPPC in the rabbit were relatively nonsaturable despite exogenous administration of large amounts of lipids. On the other hand, the half-life of NBD-[SP-C] 2 as calculated from the curve obtained in Fig. 2 was 30 .1 h. However, some NBD-[SP-C] 2 was removed as NBD-SP-C, which has a shorter half-life. To correct for this, we obtained an equation composed of two parts with different removal rates (assuming 20 µg as the starting amount of NB-[SP-C] 2 ); that is,
Ϫt/17.7
where 0.22 denotes the rate of NBD-[SP-C] 2 converted to NBD-SP-C per hour (Fig. 6 ), 17.7 is the half-life of NBD-SP-C (1%) described above, and t 1/2 C 2 represents the half-life of NBD-[SP-C] 2 . We obtained a half-life of 37.5 h. The percentage of NBD-SP-C in the total recovered proteins was calculated as 0.22t ϫ 2 Ϫt/17.7 divided by C 2 t and was 17.9 and 24.3% at 24 and 48 h after instillation, respectively. These calculated values were in accordance with the observed values as summarized in Table 1 . These results suggest that the dimeric form of NBD-SP-C has a biological half-life about twice as long as the monomeric form. Interconversion of NBD-[SP-C] 2 to NBD-SP-C accelerates the apparent removal of the former. The half-lives obtained here for these proteins are, however, very long compared with those obtained for SP-A, SP-B, and DPPC in rabbit lungs (24, 25) . Extrapolation of the present results directly to the metabolism of these proteins in humans may be limited, because the amounts of lipids and proteins we used were 10-to 20-fold larger than the endogenous pools of lipids and proteins in the mouse lung, and human proteins might behave differently in the mouse lungs. Therefore, the actual clearance times of these proteins in humans should be investigated further.
BSO and DA, potent inhibitors of GSH, are widely used to inhibit GSH action (11, 23) . In vivo, we could lower the GSH level in lavage fluid to about one-fourth of the control value with BSO and with a high dose of DA. The decrease in GSH content correlated with decreased formation of NBD-SP-C; thus GSH may be one of the substances in the lung which reduces the dimer. Direct chemical oxidation of biliverdin reductase by DA was shown to induce dimerization of the enzyme (23) , but treatment of NBD-SP-C with DA in vitro did not produce NBD-[SP-C] 2 . The decreased conversion of the dimeric form of NBD-SP-C is, therefore, considered to be caused mainly by the decrease in GSH. 2 and SP-C contents in liposomes after incubation with GSH. Incubation conditions for control and GSH-treated liposomes were same as those shown in Fig. 9 . Coomassie brilliant blue-stained gels were analyzed by densitometry, and ratio of [SP-C] 2 to SP-C was calculated. Each bar represents mean Ϯ SD of 3 experiments. ଙ Statistically significant difference at P Ͻ 0.05.
In vitro, we showed that GSH sufficiently converted NBD-[SP-C] 2 to NBD-SP-C. This reaction was not dependent on the presence of enzymes and proceeded even at 4°C at a high concentration of GSH. The concentration range (0.2-1 mM), which corresponded to that of GSH in mouse alveoli, effectively induced the conversion. The efficiency of conversion decreased to only one-half despite the decrease in the concentration of GSH from 1 to 0.1 mM. This explains why the reaction proceeded in animals, extensively treated with BSO and DA, in which GSH concentration was reduced to one-fourth of the control value.
The reason for the presence of a large amount of [SP-C] 2 in PAP is not clear. More than one-half of the cysteinyl residues of SP-C in PAP are depalmitoylated (19) , and, if the reducing activity in the lung is not sufficient, dimers may be formed. However, as shown here, the conversion of a monomer to a dimer is negligible in normal lung. GSH treatment of liposomes slightly accelerated the removal of [SP-C] 2 at 24 h after instillation, and GSH may participate in the metabolism of these hydrophobic proteins. However, we failed to reduce GSH levels continuously for a prolonged period, as there was significant rebound of these levels. Therefore it is a matter for further investigation whether the inhibition of reducing activity in the lung is accompanied by an overaccumulation and a delay in the removal of the dimeric form of SP-C. Recently, it was reported that mice deficient in granulocyte/macrophage colony-stimulating factor exhibited overaccumulation of surfactant lipids and proteins, similar to the conditions in human PAP and the abnormalities in type II cell and/or macrophage function that are suspected to cause PAP (13, 14) . Precise comparison of the status of the hydrophobic SP is required between the mouse model and human PAP, and such comparison may give further insight into the pathogenesis of these conditions.
